BackgroundNirmatrelvir with ritonavir (Paxlovid) is indicated for patients with Coronavirus Disease 2019 (COVID-19) who are at risk for progression to severe disease due to the presence of one or more risk factors. Millions of treatment courses have been prescribed in the United States alone. Paxlovid was highly effective at preventing hospitalization and death in clinical trials. https://www.hindigyanvishv.com/flash-deal-Iowa-Cubs-Foam-Finger-p32059-hot-value/